Workflow
Novartis Posts Results Above Estimates, Raises Outlook
NVSNovartis(NVS) Investopedia·2024-10-29 11:40

KEY TAKEAWAYSNovartis posted third-quarter results that beat analysts' estimates and raised its full-year outlook, buoyed by strong sales of drugs like breast-cancer treatment Kisqali.The Swiss pharmaceutical firm now forecasts 2024 core operating income growth of a high-teens percentage, compared with its previous target of a mid- to high-teens percentage.Novartis now projects full-year net sales to grow by a low-double-digit percentage, up from a high-single-digit percentage to low-double-digit percentage ...